Frovocimab, CAS [[1643672-70-1]]

Produktübersicht

• Artikelname: Frovocimab, CAS [[1643672-70-1]]
• Artikelnummer: TGM-T77014
• Hersteller Artikelnummer: T77014
• Alternativnummer: TGM-T77014-1MG,TGM-T77014-5MG,TGM-T77014-10MG,TGM-T77014-25MG,TGM-T77014-50MG,TGM-T77014-100MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: LY3015014 , LY 3015014

Produktbeschreibung

Frovocimab (LY 3015014) is a humanized IgG4 monoclonal antibody to Subtilisin/Kexin Protein Converting Enzyme Type 9 (PCSK9) that binds to the catalytic domain of PCSK9 and lowers low-density lipoprotein cholesterol (LDL-C) in patients with hypercholesterolemia.Frovocimab is used in the study of hypercholesterolemia. Frovocimab is used to study hypercholesterolemia.

Produkteigenschaften

• Reinheit: 95.30%
• CAS Nummer: [1643672-70-1]
• Target-Kategorie: Others